PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Clinical Investigation

• Publication date

  2006-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI28057PMID 16917540PMCID PMC1550279
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

  2005cited by this paper
• Regulatory T-cell therapy: is it ready for the clinic?

  2005cited by this paper
• Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

  2005cited by this paper
• Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

  2004cited by this paper
• The Loss of PTEN Allows TCR Lineage Thymocytes to Bypass IL-7 and Pre-TCR–mediated Signaling

  2004cited by this paper
• In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes

  2004cited by this paper
• Tregs and transplantation tolerance.

  2004cited by this paper
• Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells1

  2004cited by this paper
• Tolerance, not immunity, crucially depends on IL-2

  2004cited by this paper
• L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection.

  2004cited by this paper
• IL-2, Regulatory T Cells, and Tolerance

  2004cited by this paper
• Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State

  2003cited by this paper
• Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo.

  2003cited by this paper
• PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression

  2003cited by this paper
• Distinct Effects of STAT5 Activation on CD4+ and CD8+ T Cell Homeostasis: Development of CD4+CD25+ Regulatory T Cells versus CD8+ Memory T Cells 1

  2003cited by this paper
• Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1

  2003cited by this paper
• T Cell Regulation as a Side Effect of Homeostasis and Competition

  2003cited by this paper
• Essential Role for STAT5 Signaling in CD25+CD4+ Regulatory T Cell Homeostasis and the Maintenance of Self-Tolerance1

  2003cited by this paper
• PTEN: The down side of PI 3-kinase signalling.

  2002cited by this paper
• CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2.

  2002cited by this paper
• The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells.

  2002cited by this paper
• The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

  2002cited by this paper
• Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.

  2002cited by this paper
• CD25+CD4+ T cells contribute to the control of memory CD8+ T cells

  2002cited by this paper
• Phosphoinositide 3-kinase in immunological systems.

  2002cited by this paper
• Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease

  2001cited by this paper
• A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival.

  2001cited by this paper
• Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength.

  2001cited by this paper
• T cell-specific loss of Pten leads to defects in central and peripheral tolerance.

  2001cited by this paper
• An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation

  1999cited by this paper
• Impaired Fas response and autoimmunity in Pten+/- mice.

  1999cited by this paper
• Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state.

  1998cited by this paper
• CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production

  1998cited by this paper
• Biology of the interleukin-2 receptor.

  1998cited by this paper
• Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F.

  1997cited by this paper

• T Cell Development: From T-Lineage Specification to Intrathymic Maturation.

  2025cites this paper
• T Cell-Specific Inactivation of the PI3K p110α Catalytic Subunit: Effect in T Cell Differentiation and Antigen-Specific Responses

  2025cites this paper
• BLIMP1 negatively regulates IL-2 signaling in T cells

  2025cites this paper
• DF6215, an α-optimized IL-2-Fc fusion, expands immune effectors and drives robust preclinical anti-tumor activity

  2025cites this paper
• Growth of human regulatory CD4+ T cells is more tightly controlled than effector T cells due to distinctive molecular programming

  2025cites this paper
• PD-1, BTLA and TIGIT as therapeutic targets for rheumatic disease

  2025influential citation
• IL-2 based cancer immunotherapies: an evolving paradigm

  2024cites this paper
• Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.

  2024cites this paper
• Revival of recombinant IL-2 therapy – approaches from the past until today

  2024cites this paper
• Myeloid PTEN loss affects the therapeutic response by promoting stress granule assembly and impairing phagocytosis by macrophages in breast cancer

  2024cites this paper
• IL-2 immunotherapy for targeting regulatory T cells in autoimmunity

  2023cites this paper
• CD25: A potential tumor therapeutic target

  2022cites this paper
• New therapeutic strategies based on biasing IL-2 mutants for cancers and autoimmune diseases.

  2022cites this paper
• PTEN is required for human Treg suppression of costimulation

  2022influential citation
• IL-36 cytokines imprint a colitogenic phenotype on CD4+ T helper cells

  2022cites this paper
• IL-2-based approaches to Treg enhancement

  2022cites this paper
• PTEN directs developmental and metabolic signaling for innate-like T cell fate and tissue homeostasis

  2022cites this paper
• The IL-2A receptor pathway and its role in lymphocyte differentiation and function.

  2022cites this paper
• Interleukin-2 and regulatory T cells in rheumatic diseases

  2021cites this paper
• MTOR Signaling and Metabolism in Early T Cell Development

  2021cites this paper
• Recruitment and Expansion of Tregs Cells in the Tumor Environment—How to Target Them?

  2021cites this paper
• Ssu72 is a T-cell receptor-responsive modifier that is indispensable for regulatory T cells

  2021cites this paper
• The double-edged sword: Harnessing PD-1 blockade in tumor and autoimmunity

  2021cites this paper
• Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin-induced diabetes

  2021cites this paper
• mTOR signaling at the crossroads of environmental signals and T‐cell fate decisions

  2020cites this paper
• Exosome and Secretion: Action On?

  2020cites this paper
• Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy

  2020cites this paper
• Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy

  2020cites this paper
• PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy

  2020cites this paper
• Metabolic signaling in T cells

  2020cites this paper
• Potential clinical value of interleukin-31 and interleukin-33 with their receptors expression as diagnostic and predictive factors in endometrial cancer: a case-control study.

  2020cites this paper
• Noncoding RNAs: the shot callers in tumor immune escape

  2020cites this paper
• Donor bone-marrow CXCR4+ Foxp3+ T-regulatory cells are essential for costimulation blockade-induced long-term survival of murine limb transplants

  2020cites this paper
• PTEN as a Guardian of the Genome: Pathways and Targets.

  2020cites this paper
• Signaling networks in immunometabolism

  2020cites this paper
• Progress in interleukin‐2 therapy for rheumatic immune diseases by regulating the immune balance of T cells

  2019cites this paper
• mTOR: A double‐edged sword for diabetes

  2019cites this paper
• CD4 regulatory T cells: their requirement for CD80 and CD86 costimulation and their role in autoimmune hepatitis

  2019cites this paper
• Computational Infrastructures for biomolecular research

  2019cites this paper
• Metabolic Control of Treg Cell Stability, Plasticity, and Tissue-Specific Heterogeneity

  2019cites this paper
• Metabolic Pathways Involved in Regulatory T Cell Functionality

  2019cites this paper
• Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story

  2019cites this paper
• Evaluation of PTEN and CD4+FOXP3+ T cell expressions as diagnostic and predictive factors in endometrial cancer

  2019cites this paper
• The Modulation of Regulatory T Cells via HMGB1/PTEN/β-Catenin Axis in LPS Induced Acute Lung Injury

  2019cites this paper
• Acylglycerol Kinase Maintains Metabolic State and Immune Responses of CD8+ T Cells.

  2019cites this paper
• CD25 and Protein Phosphatase 2A Cooperate to Enhance IL-2R Signaling in Human Regulatory T Cells

  2019cites this paper
• New therapeutic strategies based on IL-2 to modulate Treg cells for autoimmune diseases.

  2019cites this paper
• Hypoxia-inducible factors in CD4+ T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity

  2019influential citation
• The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function

  2019cites this paper
• Expression of a Functional IL-2 Receptor in Vascular Smooth Muscle Cells

  2018cites this paper
• The PI3K/AKT signaling pathway in regulatory T‐cell development, stability, and function

  2018cites this paper
• Cytokine Signaling in the Development and Homeostasis of Regulatory T cells.

  2018cites this paper
• Tumor-derived exosomes, microRNAs, and cancer immune suppression

  2018cites this paper
• Hippo Kinases Mst1 and Mst2 Sense and Amplify IL‐2R‐STAT5 Signaling in Regulatory T Cells to Establish Stable Regulatory Activity

  2018cites this paper
• T11TS immunotherapy repairs PI3K‐AKT signaling in T‐cells: Clues toward enhanced T‐cell survival in rat glioma model

  2018cites this paper
• Regulatory T cells in the treatment of disease

  2018cites this paper
• The Therapeutic Potential of Metformin in Neurodegenerative Diseases

  2018cites this paper
• The Secrets of T Cell Polarization

  2018cites this paper
• Regulatory T Cells: Broadening Applicability

  2018cites this paper
• Cutting Edge: TGF-β and Phosphatidylinositol 3-Kinase Signals Modulate Distinct Metabolism of Regulatory T Cell Subsets

  2018cites this paper
• The effects of the citrullinating enzyme, peptidylarginine deiminase, on the activation of T cells

  2017cites this paper
• The functions of tumor suppressor PTEN in innate and adaptive immunity

  2017cites this paper
• Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells

  2017cites this paper
• The emerging role of anti‐CD25 directed therapies as both immune modulators and targeted agents in cancer

  2017cites this paper
• Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease

  2016cites this paper
• Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.

  2016cites this paper
• Empowering Regulatory T Cells in Autoimmunity.

  2016cites this paper
• Inducing and Administering Tregs to Treat Human Disease

  2016cites this paper
• Title Harnessing the plasticity of CD 4 + T cells to treat immune-mediated disease

  2016cites this paper
• Secreted microRNAs from tumor cells can suppress immune function

  2016cites this paper
• in cells maintains lineage stability.

  2016cites this paper
• Immunopharmacology

  2016cites this paper
• Hypoxic culture conditions enhance the generation of regulatory T cells

  2015cites this paper
• PTENtiating autoimmunity through Treg cell deregulation

  2015cites this paper
• The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

  2015cites this paper
• A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk

  2015cites this paper
• Regulatory T cells require the phosphatase PTEN to restrain type 1 and follicular helper T-cell responses

  2015cites this paper
• Roles of TRAF3 in T cells: many surprises

  2015cites this paper
• mTOR Links Environmental Signals to T Cell Fate Decisions

  2015influential citation
• Foxp3‐mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells

  2015influential citation
• Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes

  2015cites this paper
• MiR‐21 controls in situ expansion of CCR6+ regulatory T cells through PTEN/AKT pathway in breast cancer

  2015cites this paper
• T-cell energy metabolism as a controller of cell fate in transplantation

  2015cites this paper
• Cytolytic Function PTEN Is a Negative Regulator of NK Cell

  2015cites this paper
• Reduced Tregs in peripheral blood of PCOS patients - a consequence of aberrant Il2 signaling.

  2015cites this paper
• Tumor-secreted microRNAs act as intercellular communication mediators to manipulate the host immune system

  2015cites this paper
• Defining a Role for T Regulatory Cell Expressed MyD88 During the Response to Allografts

  2015cites this paper
• Manipulation of effector and memory cd8+ T cells via IL-2-antibody complexes

  2015cites this paper
• PTEN Is a Negative Regulator of NK Cell Cytolytic Function

  2015cites this paper
• The phosphatase PTEN-mediated control of PI-3 kinase in T regs cells maintains homeostasis and lineage stability

  2015cites this paper
• The role of IL-2Rbeta-dependent signaling and CD103 in regulatory T cells for mucosal tolerance

  2014cites this paper
• Signals and pathways controlling regulatory T cells

  2014cites this paper
• Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases.

  2014cites this paper
• Recherche de thérapies innovantes dans un modèle murin de myopathies inflammatoires

  2014cites this paper
• Selective Inhibition of Regulatory T Cells by Targeting the PI3K–Akt Pathway

  2014cites this paper
• Selective inhibition of regulatory T cells by targeting PI 3 K-Akt pathway

  2014influential citation
• Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth

  2014cites this paper
• The adaptor molecule TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating interleukin-2 receptor signaling

  2014cites this paper
• Silver and fullerene nanoparticles' effect on interleukin-2-dependent proliferation of CD4 (+) T cells.

  2014cites this paper
• Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4+ T Cells of Patients with Relapsing-Remitting Multiple Sclerosis

  2014cites this paper